The Investment Column: Amersham sees hope of a cure
The change in "tone" in the industry, evident in the second half, is already boosting sales of Amersham's technology and services. Its drug development services, used in testing and screening new pharmaceuticals, molecular biology, where Amersham leads the market, and genetic sequencing, increasingly used by drugs groups to short-cut the search for new drugs, reported sales growth of between 10 and 17 per cent last year. The improvement helped return Amersham's main life sciences division to growth in the second half. But group profits up from pounds 47.3m to pounds 50.8m owed most of their growth to foreign exchange benefits, which added pounds 4.5m to the bottom line.
Healthcare, the pharmaceutical and diagnostic division, has continued to grow on the back of Amersham's already strong position in nuclear medicine. The main Ceretec brain imaging agent saw sales dip 8 per cent to pounds 22.3m under the onslaught of competition from Du Pont's Neurolite, but Metastron, for pain caused by bone cancer, now sells nearly as well and the hope for the future is Myoview, the heart imaging agent. Amersham will receive a boost to earnings from raising its stake in the Japanese Nihon Medi- Physics to 50 per cent from October and give it a third of the world market for nuclear medicine.
The omens are better than they have been for some time for Amersham, but even profits of pounds 63m this year would put the shares, up 28p at pounds 10.43, on a prospective p/e ratio of 17. Hold.
- 1 Pope Francis issues top 10 tips for happiness
- 2 Disney heiress Abigail disowns her share of family profits in West Bank company
- 3 The secret report that helps Israel hide facts
- 4 Now diplomacy has failed, boycotting Israel might be the only way we can protect the people of Gaza
- 5 Israel's propaganda machine is finally starting to misfire
Russell Brand accuses Sean Hannity of terrorism after aggressive Israel-Gaza debate
Pope Francis issues top 10 tips for happiness
Justin Bieber posts Instagram photo of a crying Orlando Bloom after Ibiza fight 'over Miranda Kerr'
Disney heiress Abigail disowns her share of family profits in West Bank company
Air Algerie AH5017 crash: Jet fell 30,000 feet in three minutes ‘due to violent storm’
The secret report that helps Israel hide facts
Land for gas: Merkel and Putin discussed secret deal could end Ukraine crisis
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Boozy, ignorant, intolerant, but very polite – Britain as others see us
- < Previous
- Next >
iJobs Money & Business
£28000 - £32000 per annum + benefits: Ashdown Group: Training Programme Manage...
£20000 - £24000 per annum: Harrington Starr: A leading provider of web based m...
£28000 - £32000 per annum: Ashdown Group: Secretary (Sales Team Support) - Mat...
Competitive (DOE): Guru Careers: We are looking for an Assistant Management Ac...